Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.06 Nov 4, 2025 05:23PM
Cumberland Pharmaceuticals partners with RedHill for Talicia commercialization Oct 20, 2025 09:05AM
Cumberland Pharmaceuticals gets Mexico approval for injectable ibuprofen Oct 1, 2025 09:06AM
Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.02 Aug 5, 2025 04:39PM
Cumberland Pharmaceuticals secures Vizient contract for Vibativ antibiotic Aug 4, 2025 09:05AM


Jun 23, 2025 09:06AM Cumberland Pharmaceuticals (CPIX) Shares Phase 2 FIGHT DMD Trial Results
May 27, 2025 04:09PM Cumberland Pharmaceuticals (CPIX) announces results from study on Caldolor
May 6, 2025 04:23PM Cumberland Pharmaceuticals (CPIX) Reports Q1 EPS of $0.16
Mar 4, 2025 04:06PM Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.14
Feb 4, 2025 07:30AM Cumberland Pharmaceuticals (CPIX) Announces Results from the Phase 2 FIGHT DMD Trial
Dec 10, 2024 08:24AM Cumberland Pharmaceuticals (CPIX): FDA Approves Acetadote SNDA
Nov 7, 2024 04:38PM Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11
Nov 6, 2024 05:22PM Cumberland Pharmaceuticals (CPIX) Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Ifetroban
Aug 6, 2024 04:51PM Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.01